Clinical Trials Browser

Phase 1 × Neuroblastoma × Cefixime × Clear all

NCT00644696 2017-07-06

Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00093353 2010-10-15

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Phase 1 Completed

Diarrhea, Neuroblastoma, Drug-Related Side Effects and Adverse Reactions